Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

NCT07288814 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Peripheral T Cell Lymphoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome & Enlonstobart

Sponsor

Sun Yat-Sen University Cancer Center

Collaborators

[object Object]